People aged ≥6 months with medical conditions associated with an increased risk of influenza disease and complications are recommended to receive influenza vaccine every year
People aged ≥6 months with medical conditions specified in this Table. Specified medical conditions associated with increased risk of influenza disease and severe outcomes are recommended to receive annual influenza vaccine.
Influenza vaccine is funded through the NIP for people with certain medical conditions that increase their risk of severe influenza complications. For details see the National Immunisation Program Schedule.
People with these specific medical conditions have a higher risk of influenza or severe outcomes from influenza.9-29
Most children aged 2–<18 years can receive either inactivated influenza vaccine or live attenuative influenza vaccine (LAIV). However, people with certain conditions (including those who are moderately or severely immunocompromised) are contraindicated to receive LAIV. These people should receive inactivated influenza vaccine. See Contraindications for details.
Children aged 6 months to <9 years with medical risk conditions receiving influenza vaccine for the first time should receive 2 doses of influenza vaccine. A single dose is recommended in all subsequent years.
People who have received a transplant
People who have received a transplant
People who have had a haematopoietic stem cell transplant, solid organ transplant or CAR T-cell therapy and are receiving influenza vaccine for the first time after transplant are recommended to receive:
- 2 doses given at least 4 weeks apart the 1st time they receive influenza vaccine after the transplant
- 1 dose each year after that
| Conditions | Example medical conditions | NIP funded |
|---|---|---|
| Cardiac disease |
|
Yes |
| Chronic respiratory condition |
|
Yes |
| Immunocompromising condition |
|
Yes |
| Haematological disorder |
|
Yes |
| Chronic metabolic disorder |
|
Yes |
| Chronic kidney disease |
|
Yes |
| Chronic neurological condition |
|
Yes |
| Long-term aspirin therapy in children aged 5 to 10 years | Yes | |
| Chronic liver disease |
|
No |
| Obesity |
|
No |
| Chromosomal abnormality |
|
No |
| Harmful use of alcohol | No |